Pharmacological Differentiation of Presynaptic Inhibitory Alpha-adrenoceptors and Opiate Receptors in the Cat Nictitating Membrane

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1980 Nov 1

PMID 6254597

Citations 4

Authors

M L Dubocovich

S Z Langer

Affiliations

Soon will be listed here.

Abstract

1 The action of morphine, naturally occurring and synthetic opiate peptides on [3H]-noradrenaline release induced by nerve stimulation was studied in the isolated nerve muscle preparation of the cat nictitating membrane under experimental conditions in which the alpha-presynaptic receptors were blocked by phentolamine 1 microM. 2 Morphine and the naturally occurring peptides: [Met5]-enkephalin, [Leu5]-enkephalin and beta-endorphin reduced 3H-transmitter overflow and responses to nerve stimulation from the cat nictitating membrane, effects which were completely antagonized by naloxone 0.3 microM. The relative order of potency for the inhibition of the stimulation-induced 3H-transmitter overflow at the level of the IC50 (microM) was as follows: [Met5]-enkephalin (0.020 microM) greater than or equal to [Leu5]-enkephalin (0.036 microM) > morphine (0.3 microM) > beta-endorphin (1 microM). 3 The synthetic opiate pentapeptides: BW 180 C (Tyr-D-Ala-Gly-Phe-D-Leu), and BW834 C (Tyr-D-Ala-Gly-pClPhe-DLeu), which are resistant to enzymatic degradation were more potent than the enkephalins in reducing the stimulation-evoked transmitter overflow from the cat nictitating membrane. On the other hand, the tetrapeptide BW832 C, which lacks the D-leucine terminal of BW180 C l was less potent than the enkephalins in inhibiting neurotransmission. 4 In the presence of phenoxybenzamine 1 microM, 3H-transmitter overflow was increased 8 fold and the inhibition of neurotransmission by methionine-enkephalin was not affected. Exposure to phenoxybenzamine 10 microM increased [3H]-noradrenaline overflow 15 fold and antagonized the effects of methionine enkephalin on transmitter release. 5 In the cat nictitating membrane the inhibitory presynaptic opiate receptors are different from the presynaptic alpha-autoreceptors which regulate the release of noradrenaline elicited by nerve depolarization through a negative feed-back mechanism.

Citing Articles

Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation.

Nakaki T, Nakadate T, Yamamoto S, Kato R Naunyn Schmiedebergs Arch Pharmacol. 1982; 318(3):181-4.

PMID: 6121295 DOI: 10.1007/BF00500478.

Interaction between presynaptic facilitatory angiotensin II receptors and inhibitory muscarinic cholinoceptors on 3H-noradrenaline release in the rabbit heart.

Garcia-Sevilla J, Dubocovich M, Langer S Naunyn Schmiedebergs Arch Pharmacol. 1985; 330(1):9-15.

PMID: 2995842 DOI: 10.1007/BF00586703.

Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.

Limberger N, Spath L, Starke K Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(1):53-61.

PMID: 2907100 DOI: 10.1007/BF00168812.

Enkephalinergic inhibition in parasympathetic ganglia of the urinary bladder of the cat.

de Groat W, Kawatani M J Physiol. 1989; 413:13-29.

PMID: 2600844 PMC: 1189086. DOI: 10.1113/jphysiol.1989.sp017639.

References

Starke K . Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1972; 274(1):18-45. DOI: 10.1007/BF00501004. View

Taube H, Borowski E, Endo T, Starke K . Enkephalin: a potential modulator of noradrenaline release in rat brain. Eur J Pharmacol. 1976; 38(2):377-80. DOI: 10.1016/0014-2999(76)90343-5. View

Arbilla S, Langer S . Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature. 1978; 271(5645):559-61. DOI: 10.1038/271559a0. View

Montel H, Starke K, Weber F . Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol. 1974; 283(4):357-69. DOI: 10.1007/BF00501109. View

Walton K, Liepmann P, Baldessarini R . Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine. Eur J Pharmacol. 1978; 52(2):231-4. DOI: 10.1016/0014-2999(78)90211-x. View

Enero M, Langer S . Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naunyn Schmiedebergs Arch Pharmacol. 1975; 289(2):179-203. DOI: 10.1007/BF00501305. View

Pert C, Pert A, Tallman J . Isolation of a novel endogenous opiate analgesic from human blood. Proc Natl Acad Sci U S A. 1976; 73(7):2226-30. PMC: 430506. DOI: 10.1073/pnas.73.7.2226. View

Henderson G, Hughes J, Thompson J . The variation of noradrenaline output with frequency of nerve stimulation and the effect of morphine on the cat nictitating membrane and on the guinea-pig myenteric plexus. Br J Pharmacol. 1972; 46(3):524P-525P. PMC: 1666545. View

Baxter M, Goff D, Miller A, Saunders I . Effect of a potent synthetic opioid pentapeptide in some anti-nociceptive and behavioural tests in mice and rats [proceedings]. Br J Pharmacol. 1977; 59(3):455P-456P. PMC: 1667974. View

10.

Waterfield A, LORD J, Hughes J, KOSTERLITZ H . Differences in the inhibitory effects of normorphine and opioid peptides on the responses of the vasa deferentia of two strains of mice. Eur J Pharmacol. 1978; 47(2):249-50. DOI: 10.1016/0014-2999(78)90399-0. View

11.

Langer S, Enero M . The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: its relationship to the metabolic fate of released norepinephrine. J Pharmacol Exp Ther. 1974; 191(3):431-43. View

12.

LORD J, Waterfield A, Hughes J, KOSTERLITZ H . Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977; 267(5611):495-9. DOI: 10.1038/267495a0. View

13.

Taube H, Starke K, Borowski E . Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1977; 299(2):123-41. DOI: 10.1007/BF00498554. View

14.

Hughes J, Smith T, KOSTERLITZ H, Fothergill L, Morgan B, Morris H . Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975; 258(5536):577-80. DOI: 10.1038/258577a0. View

15.

Morgan B, Smith C, Waterfield A, Hughes J, KOSTERLITZ H . Structure-activity relationships of methionine-enkephalin. J Pharm Pharmacol. 1976; 28(8):660-1. DOI: 10.1111/j.2042-7158.1976.tb02827.x. View

16.

North R, Henderson G . Action of morphine on guinea-pig myenteric plexus and mouse vas deferens studied by intracellular recording. Life Sci. 1975; 17(1):63-6. DOI: 10.1016/0024-3205(75)90236-2. View

17.

Henderson G, Hughes J, KOSTERLITZ H . The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation. Br J Pharmacol. 1975; 53(4):505-12. PMC: 1666318. DOI: 10.1111/j.1476-5381.1975.tb07387.x. View

18.

Aghajanian G . Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 1978; 276(5684):186-8. DOI: 10.1038/276186a0. View

19.

Hill R, Pepper C . The depression of thalamic nociceptive neurones by D-ala2,D-leu5-enkephalin. Eur J Pharmacol. 1978; 47(2):223-5. DOI: 10.1016/0014-2999(78)90393-x. View

20.

Hughes J, KOSTERLITZ H, Leslie F . Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol. 1975; 53(3):371-81. PMC: 1666422. DOI: 10.1111/j.1476-5381.1975.tb07373.x. View